Thus, in lupus-prone mice, SCFAs dampen B cell AID and Blimp1 expression, plasma cell differentiation, systemic class-switched autoantibodies, and abolish lupus skin lesions and kidney pathology. Here, PRDM1 is linked to systemic lupus erythematosus.